Researchers show that LAG3-directed #Interleukin2 selectively boosts tumor-specificT cells, preventing exhaustion and restoring #AntiTumor activity, highlighting a potential strategy to enhance #Cancer #Immunotherapy efficacy. @tsinghuauniversity.bsky.social
doi.org/10.1038/s413...
Signal Transduction and Targeted Therapy